BlackRock Investment Management, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,349,000
-18.5%
950,129
+0.5%
0.00%0.0%
Q3 2016$1,655,000
+2.2%
945,725
-0.2%
0.00%0.0%
Q2 2016$1,620,000
-1.7%
947,551
+13.3%
0.00%0.0%
Q1 2016$1,648,000
+6.6%
836,603
+2.8%
0.00%0.0%
Q4 2015$1,546,000
-0.8%
813,789
-0.3%
0.00%0.0%
Q3 2015$1,558,000
-59.1%
815,877
-0.6%
0.00%
-60.0%
Q2 2015$3,807,000
+30.4%
820,461
+22.8%
0.01%
+25.0%
Q1 2015$2,920,000
+40.2%
668,239
+11.4%
0.00%
+33.3%
Q4 2014$2,082,000
-17.8%
599,904
-0.8%
0.00%
-25.0%
Q3 2014$2,533,000
-28.1%
604,639
+0.6%
0.00%
-20.0%
Q2 2014$3,523,000
-9.6%
601,165
-2.9%
0.01%
-16.7%
Q1 2014$3,899,000
+8.3%
618,938
+0.5%
0.01%
+20.0%
Q4 2013$3,601,000
+8.3%
615,624
-2.5%
0.01%0.0%
Q3 2013$3,326,000
-27.8%
631,159
+5.5%
0.01%
-37.5%
Q2 2013$4,608,000598,3850.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 7,500,000$34,800,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,983,710$32,404,0001.08%
DAFNA Capital Management LLC 189,000$877,0000.74%
Lyons Wealth Management, LLC. 56,665$264,0000.30%
Telemetry Investments, L.L.C. 110,000$510,0000.23%
Callan Capital, LLC 232,000$1,076,0000.23%
OXFORD ASSET MANAGEMENT LLP 968,446$4,494,0000.12%
FEDERATED HERMES, INC. 5,641,200$26,175,0000.08%
HRT FINANCIAL LP 31,973$148,0000.07%
WELLINGTON MANAGEMENT GROUP LLP 33,885,551$157,230,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders